{"DataElement":{"publicId":"8035892","version":"1","preferredName":"Amino Acid Sequence Change ALK Tyrosine Kinase Receptor Detection Text","preferredDefinition":"The free-text field to describe the amino acid sequencing change(s) detected in the ALK tyrosine kinase receptor.","longName":"AA_SEQ_CHNG_ALK_DECT_TXT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"8035886","version":"1","preferredName":"Amino Acid Sequence Change ALK Tyrosine Kinase Receptor Detection","preferredDefinition":"The sequence of amino acids along a polypeptide chain._The act of alteration or modification; changed or altered in form or character.:ALK tyrosine kinase receptor (1620 aa, ~176 kDa) is encoded by the human ALK gene. This protein is involved in ligand binding, tyrosine phosphorylation and signal transduction._The activity of perceiving, discerning, discovering or identifying.","longName":"3028516v1.0:8035884v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2671632","version":"1","preferredName":"Protein Sequence Change","preferredDefinition":"The sequence of amino acids along a polypeptide chain.:The act of alteration or modification; changed or altered in form or character.","longName":"C13187:C25446","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Amino Acid Sequence","conceptCode":"C13187","definition":"The sequence of amino acids along a polypeptide chain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3793E842-CF7E-50FC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-13","endDate":null,"createdBy":"UMLLOADER_CPAS","dateCreated":"2007-08-13","modifiedBy":"ONEDATA","dateModified":"2007-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"11167656","version":"1","preferredName":"ALK Tyrosine Kinase Receptor Detection","preferredDefinition":"ALK tyrosine kinase receptor (1620 aa, ~176 kDa) is encoded by the human ALK gene. This protein is involved in ligand binding, tyrosine phosphorylation and signal transduction._The activity of perceiving, discerning, discovering or identifying.","longName":"C27032:C16210","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ALK Tyrosine Kinase Receptor","conceptCode":"C27032","definition":"ALK tyrosine kinase receptor (1620 aa, ~176 kDa) is encoded by the human ALK gene. This protein is involved in ligand binding, tyrosine phosphorylation and signal transduction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Detection","conceptCode":"C16210","definition":"The act of perceiving, discerning, discovering, or identifying.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7A2AB9E-F7A6-1393-E053-731AD00AB5D3","latestVersionIndicator":"Yes","beginDate":"2022-09-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-09-01","modifiedBy":"KUMMEROA","dateModified":"2022-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7A1E679-D1A7-4DC1-E053-4EBD850A3F8B","latestVersionIndicator":"Yes","beginDate":"2022-02-09","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2022-02-09","modifiedBy":"CLOHNES","dateModified":"2022-09-07","changeDescription":"2/9/2022 created for ANBL study, wz.","administrativeNotes":"9/7/22 Released DEC per AK for COG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6784451","version":"1","preferredName":"255 Character Text","preferredDefinition":"The words of something written.","longName":"6784451v1.0","context":"OCCPR","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"255","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8BA00B33-81DA-0AB8-E053-F662850A521F","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-18","modifiedBy":"KNABLEJ","dateModified":"2020-06-23","changeDescription":"11/10/19 jk Released per CPTAC SME (Linda) for Medical History CRF.  6-18-19 tt created for CPTAC Medical History CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Specify the amino acid sequencing change(s) detected in the ALK tyrosine kinase receptor:","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Provide data on substituted amino acid (enter the full protein change, such as \"p.R1275Q\"):","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7A2BDD7-A311-5656-E053-4EBD850A001F","latestVersionIndicator":"Yes","beginDate":"2022-02-09","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2022-02-09","modifiedBy":"CLOHNES","dateModified":"2022-09-07","changeDescription":"2/9/2022 created for ANBL study, wz.","administrativeNotes":"9/7/22 Released CDE per AK for COG cjl;","unresolvedIssues":null,"deletedIndicator":"No"}}